Malaria Parasite and Mosquito Products and Assay Services Available for Sale by Sanaria

ROCKVILLE, Maryland, June 29, 2011 -

Sanaria’s mission is to develop and commercialize whole-parasite
malaria vaccines that confer high-level, long-lasting protection
against malaria caused by Plasmodium falciparum and P.
vivax. In the process of developing these vaccines, Sanaria has
developed the capacity to manufacture and assay malaria parasites
and mosquitoes in a highly regulated, cGMP compliant, industrial
setting. These parasites, mosquitoes, and assay services are now
available to the general research community as Sanaria Inc.
announces the launch of its Sanaria ^® 
Family of Products and Services intended to advance research
towards new malaria vaccines, drugs, and diagnostics, and enhanced
understanding of malaria pathology and immunobiology.

Sanaria ^®  Plasmodium
falciparum Sporozoite Reagents :  Aseptic,
purified, vialed, cryopreserved, attenuated and non-attenuated
Plasmodium falciparum (Pf) sporozoites.

Sanaria ^®  PfSPZ Challenge
Mosquitoes :  Live, aseptic and non-aseptic P.
falciparum infected mosquitoes. These well-characterized
mosquitoes are for experimentally challenging volunteers in studies
assessing malaria vaccines and drugs and for laboratory-based
research.

Sanaria ^® 
Plasmodium Reagents :  Purified,
vialed, cryopreserved, attenuated and non-attenuated
Plasmodium species sporozoites, as well as other life cycle
stages for laboratory-based research studies.  

Sanaria ^® 
Plasmodium Reagent Slides : Slides for
immunofluorescence assays to detect antibodies against purified
sporozoite, and asexual erythrocytic, sexual erythrocytic and/or
mosquito stages of Plasmodium species.

Sanaria ^® 
Anopheles Reagents : Aseptic and
non-aseptic Anopheles stephensi mosquitoes and derived
material for laboratory-based research studies.

Sanaria ^® 
Plasmodium Assay Services : Assessment
of the effects of antibodies and drugs on the capacity of P.
falciparum and P. vivax sporozoites to invade and
develop in hepatocytes (inhibition of sporozoite invasion and
inhibition of liver stage development assay), and of P.
falciparum gametocytes to develop to oocysts and sporozoites in
mosquitoes (transmission blocking assay). Assessment of antibodies
to all life cycle stages of Plasmodium species by
immunofluoresence assays and to selected antigens by ELISA.

Monoclonal Antibodies: Sporozoite, liver, and
blood stage monoclonal antibodies.

Sanaria ^®  Custom
Services: Sanaria will manufacture Plasmodium
species reagents to meet your specifications.

For more information please visit href="www.sanaria.com/">www.sanaria.com. For
pricing and other information please e-mail href="mailto:sales@sanaria.com">sales@sanaria.com.

Except for historical information, this news release contains
certain forward-looking statements that involve known and unknown
risk and uncertainties, which may cause actual results to differ
materially from any future results, performance or achievements
expressed or implied by the statements made. These forward-looking
statements are further qualified by important factors that could
cause actual results to differ materially from those in the
forward-looking statements. Public Relations Contact: href="mailto:arichman@sanaria.com">arichman@sanaria.com
Investor Contact: href="mailto:rcthompson@sanaria.com">rcthompson@sanaria.com

Sanaria Inc. Public Relations: +1-301-770-3222